PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics, Inc. (PTCT) is a healthcare company (biotechnology) based in the United States. The share price is $60.00, down 1.60% on the day, which values the company at $5.01B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.

Key facts

Share price
$60.00−1.60% today
Market value
$5.01B
Forward P/E
18.8×
Funk Score
74/100
200-week average
$49.1622% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

PTC Therapeutics, Inc. in more detail

PTCT trades at 18.8× next year's expected earnings, 4.3× sales. It sits 22% above its 200-week average of $49.16.

Over the last five fiscal years PTC Therapeutics, Inc. has compounded revenue 35.4% a year. Its Funk Score is 74 out of 100 (financial strength 4.7, profitability 8.2, growth 9.3, each out of 10).

In its favour: Strong Piotroski score; Operating margin is expanding. Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

1 of the superinvestors tracked here hold PTCT, including Louis Bacon (0.4% of the portfolio).

Superinvestors holding PTCT

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:PTCT vs HAE (PTC Therapeutics, Inc. vs Haemonetics)PTCT vs ERAS (PTC Therapeutics, Inc. vs Erasca)PTCT vs HIMS (PTC Therapeutics, Inc. vs Hims & Hers Health)PTCT vs CON (PTC Therapeutics, Inc. vs Concentra Group Holdings Parent)PTCT vs BLLN (PTC Therapeutics, Inc. vs BillionToOne)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

PTC Therapeutics, Inc. (PTCT): questions and answers

What is PTC Therapeutics, Inc.'s market cap?

PTC Therapeutics, Inc. is valued at $5.01B at a share price of $60.00.

Is PTCT above its 200-week moving average?

Yes. PTCT is 22.0% above its 200-week average of $49.16. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is PTC Therapeutics, Inc. growing?

Over the last five fiscal years PTC Therapeutics, Inc.'s revenue grew 35.4% a year; over ten years revenue grew 47.0% a year.

Does PTCT pay a dividend?

PTC Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own PTCT?

In their latest quarterly filings, Louis Bacon (0.4% of the portfolio) hold PTCT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “PTC Therapeutics, Inc. (PTCT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PTCT

Underlying data: Yahoo Finance; company filings with the SEC.